Stable crystal of 4-oxoquinoline compound

Provision of a stabilized crystal of 6-(3-chloro-2-fluorobenzyl)-1-[(S)-1-hydroxymethyl-2-methylpropyl]-7-methoxy-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid (compound A). A crystal of compound A, which shows a particular X-ray powder diffraction pattern of a characteristic diffraction peaks at di...

Full description

Saved in:
Bibliographic Details
Main Authors Satoh, Motohide, Motomura, Takahisa, Matsuda, Takashi, Kondo, Kentaro, Ando, Koji, Matsuda, Koji, Miyake, Shuji, Uehara, Hideto
Format Patent
LanguageEnglish
Published 22.12.2009
Online AccessGet full text

Cover

Abstract Provision of a stabilized crystal of 6-(3-chloro-2-fluorobenzyl)-1-[(S)-1-hydroxymethyl-2-methylpropyl]-7-methoxy-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid (compound A). A crystal of compound A, which shows a particular X-ray powder diffraction pattern of a characteristic diffraction peaks at diffraction angles 2θ(°) as measured by X-ray powder diffractmetry.
AbstractList Provision of a stabilized crystal of 6-(3-chloro-2-fluorobenzyl)-1-[(S)-1-hydroxymethyl-2-methylpropyl]-7-methoxy-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid (compound A). A crystal of compound A, which shows a particular X-ray powder diffraction pattern of a characteristic diffraction peaks at diffraction angles 2θ(°) as measured by X-ray powder diffractmetry.
Author Uehara, Hideto
Kondo, Kentaro
Satoh, Motohide
Motomura, Takahisa
Matsuda, Takashi
Matsuda, Koji
Ando, Koji
Miyake, Shuji
Author_xml – sequence: 1
  givenname: Motohide
  surname: Satoh
  fullname: Satoh, Motohide
– sequence: 2
  givenname: Takahisa
  surname: Motomura
  fullname: Motomura, Takahisa
– sequence: 3
  givenname: Takashi
  surname: Matsuda
  fullname: Matsuda, Takashi
– sequence: 4
  givenname: Kentaro
  surname: Kondo
  fullname: Kondo, Kentaro
– sequence: 5
  givenname: Koji
  surname: Ando
  fullname: Ando, Koji
– sequence: 6
  givenname: Koji
  surname: Matsuda
  fullname: Matsuda, Koji
– sequence: 7
  givenname: Shuji
  surname: Miyake
  fullname: Miyake, Shuji
– sequence: 8
  givenname: Hideto
  surname: Uehara
  fullname: Uehara, Hideto
BookMark eNrjYmDJy89L5WTQDC5JTMpJVUguqiwuScxRyE9TMNHNr8gvLM3My8_JzAPK5OcW5JfmpfAwsKYl5hSn8kJpbgYFN9cQZw_d0uKCxJLUvJLi-PSiRBBlYG5mbGpuYGJMhBIAwpgrXg
ContentType Patent
CorporateAuthor Japan Tobacco Inc
CorporateAuthor_xml – name: Japan Tobacco Inc
DBID EFH
DatabaseName USPTO Issued Patents
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EFH
  name: USPTO Issued Patents
  url: http://www.uspto.gov/patft/index.html
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
ExternalDocumentID 07635704
GroupedDBID EFH
ID FETCH-uspatents_grants_076357043
IEDL.DBID EFH
IngestDate Sun Mar 05 22:30:58 EST 2023
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-uspatents_grants_076357043
OpenAccessLink https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7635704
ParticipantIDs uspatents_grants_07635704
PatentNumber 7635704
PublicationCentury 2000
PublicationDate 20091222
PublicationDateYYYYMMDD 2009-12-22
PublicationDate_xml – month: 12
  year: 2009
  text: 20091222
  day: 22
PublicationDecade 2000
PublicationYear 2009
References Jain et al. "Polymorphisom in pharmacey" Indian Drugs 23(g)315-329 (1986).
Brittain "Polymorphism in pharmaceutical solids" Marcel Dekker inc. p. 2, (1999).
(1140851) 20011000
(10-316570) 19981200
(WO 00/01714) 20000100
Doelker et al. "Crystalline modification . . . " CA 138:209993 (2002).
Engleson "Concise encyclopedia Chemistry" p. 872-873 (1993).
Satoh et al. (2006/0019906) 20060100
Cushman et al. "Cosalane analogues . . . " J. Med. Chem. v.38, p. 443-52 (1995).
Lesher (3472859) 19691000
Knapman "polymorph prediction" The Alchemist (Oct. 1999) 1/2, p. 1-3, 2/2, p. 1-3.
Baker, J. Med. Chem, 15(3), pp. 235-237 (1972).
Matsuzaki et al. (2005/0288326) 20051200
(WO 03/010147) 20030200
(6-116241) 19940400
(2002-293745) 20021000
Petriconi et al. (2003/0138483) 20030700
(6-199835) 19940700
Bernstein "Polymorphism . . . " p. 108 (2002).
Mol. Pharmacol. 10:235-247 (1974).
Nair et al. "Influence of polyethylene glycol and povidone . . . " CA 138:260244 (2002).
Mekouar et al. (6670377) 20031200
(WO 02/36734) 20020500
Stefancich, Farmaco, Edizioje Scientific, 42(1), pp. 3-16 (1987).
(WO 02/04444) 20020100
Muzaffar et al. "Polymorphism and drug availability" J. Phar. 1(1) 59-66 (1979).
Parienti "Cytokine therapy or structured treatment . . . " CA 137:92237 (2002).
Kimura et al. (5688791) 19971100
Kimura et al. (5519016) 19960500
Goho "Tricky business" Science News online, (Aug. 2004) p. 1-9.
(WO 97/38999) 19971000
(A 48 26 772) 19730400
(6-271568) 19940900
Wikipedia "Polymorphosm" free encyclopedia (2006).
(498721) 19920800
Hirao, I. et al., Studies on the Synthesis of Quinoline Compounds, I. Memoirs Kyushu Inst. Tech. (Eng.), 14:13-16 (1984).
Vincent, K.A., et al., Characterization of Human Immunodeficiency Virus Type I Integrase Expressed In Eschericia coli and Analysis of Variants with Amino-Terminal Mutations, J. Virol. 67: 425-437 (1993).
(8-183775) 19960700
(A 2002-534416) 20021000
Doelker et al. "Physicochemical behavior or active . . . " CA 132:325872 (2000).
Chou and Talalay, Adv. Enzyme Regul. 22:27-55 (1984).
Hirao, I. et al., Antibacterial Activities of Oxodihydroquinoline Carboxylic Acid Derivatives, Memoirs Department of Engineering, 14:21-32 (1990).
Schnute (2002/0103220) 20020800
(1375486) 20040100
CMU Pharmaceutical polymorphism, internat p. 1-3 (2002) (print out Apr. 3, 2008).
Walton, Antimicrobial Agents, Chemotherapy, 32(7) pp. 10869 (1988).
Lanz et al. "Pharmaceutical powder technology . . . " (2006) p. 110.
Clemence et al. (5985894) 19991100
Satoh et al. (2005/0239819) 20051000
(1 564 210) 20050800
(WO 00/40561) 20000700
Bakale et al. (6627646) 20030900
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescent, pp. i-iii and 1-111, (Aug. 13, 2001).
(A 2002-534417) 20021000
Henck et al. "Designing a molecular . . . " Drug. disclovery Today v. 12(5/6) p. 189-199 (2007).
Turner et al. (6248739) 20010600
Fuji et al. (2004/0127708) 20040700
(WO 98/45269) 19981000
Brittain "polymorphism . . . " p. 57-58 (1999).
Ciske et al. (6559145) 20030500
Dickinson et al. (6248738) 20010600
(WO 00/40563) 20000700
(A 43 60 872) 19921200
Niazi "handbook of pharmaceutical manufacturing . . . " p. 1( form internet ) (2004).
(3567162) 20040900
Ulrich Crystallization{ Kirk-Othmer encyclopedia of chem. tech. p. 95-147 (2002).
Marsac et al. "Sppontaneous crystallinity loss . . . " J. Pharm Sci. v. 97(8) p. 3182-3194 (2008).
Kimura et al. (6034086) 20000300
US Pharmacopia #23 national formulary #18, p. 1843-1844 (1995).
Elbary et al. "Polymorphic transformation . . . " CA 136:58666 (2001).
Yoshimoto, J. Med. Chem, 19(1), pp. 71-98 (1976).
Sleasman et al. "HIV-1 infection" CA 139:305926 (2003).
(WO 02/070486) 20020900
Singhal et al. "Drug polymorphism . . . " Advanced drug delivery reviews 56. p. 335-347 (2004).
Turner et al. (6248736) 20010600
(WO 01/98275) 20011200
(WO 02/055079) 20020700
Abdul-Ahad, Europ. J. of Med. Chem, 17(4), pp. 301-306 (1982).
Otsuka et al. "effect of polymorphic . . . " Chem. Pharm. Bull, 47(6) 852-856 (1999).
PCT International Search Report (PCT/JP2005/009604) dated Nov. Oct. 28, 2005.
References_xml – year: 19940400
  ident: 6-116241
– year: 19971000
  ident: WO 97/38999
– year: 19940700
  ident: 6-199835
– year: 20020100
  ident: WO 02/04444
– year: 19960500
  ident: 5519016
  contributor:
    fullname: Kimura et al.
– year: 20021000
  ident: 2002-293745
– year: 19940900
  ident: 6-271568
– year: 19971100
  ident: 5688791
  contributor:
    fullname: Kimura et al.
– year: 20020900
  ident: WO 02/070486
– year: 20010600
  ident: 6248736
  contributor:
    fullname: Turner et al.
– year: 20000700
  ident: WO 00/40561
– year: 20000700
  ident: WO 00/40563
– year: 20051200
  ident: 2005/0288326
  contributor:
    fullname: Matsuzaki et al.
– year: 20060100
  ident: 2006/0019906
  contributor:
    fullname: Satoh et al.
– year: 20011000
  ident: 1140851
– year: 19981000
  ident: WO 98/45269
– year: 20040100
  ident: 1375486
– year: 20020800
  ident: 2002/0103220
  contributor:
    fullname: Schnute
– year: 20020700
  ident: WO 02/055079
– year: 20020500
  ident: WO 02/36734
– year: 19691000
  ident: 3472859
  contributor:
    fullname: Lesher
– year: 20030200
  ident: WO 03/010147
– year: 20040900
  ident: 3567162
– year: 20011200
  ident: WO 01/98275
– year: 20050800
  ident: 1 564 210
– year: 20010600
  ident: 6248738
  contributor:
    fullname: Dickinson et al.
– year: 20030900
  ident: 6627646
  contributor:
    fullname: Bakale et al.
– year: 20051000
  ident: 2005/0239819
  contributor:
    fullname: Satoh et al.
– year: 19981200
  ident: 10-316570
– year: 20030500
  ident: 6559145
  contributor:
    fullname: Ciske et al.
– year: 19730400
  ident: A 48 26 772
– year: 19960700
  ident: 8-183775
– year: 19920800
  ident: 498721
– year: 20031200
  ident: 6670377
  contributor:
    fullname: Mekouar et al.
– year: 20000300
  ident: 6034086
  contributor:
    fullname: Kimura et al.
– year: 19921200
  ident: A 43 60 872
– year: 20010600
  ident: 6248739
  contributor:
    fullname: Turner et al.
– year: 20000100
  ident: WO 00/01714
– year: 19991100
  ident: 5985894
  contributor:
    fullname: Clemence et al.
– year: 20021000
  ident: A 2002-534416
– year: 20040700
  ident: 2004/0127708
  contributor:
    fullname: Fuji et al.
– year: 20021000
  ident: A 2002-534417
– year: 20030700
  ident: 2003/0138483
  contributor:
    fullname: Petriconi et al.
Score 2.755962
Snippet Provision of a stabilized crystal of 6-(3-chloro-2-fluorobenzyl)-1-[(S)-1-hydroxymethyl-2-methylpropyl]-7-methoxy-4-oxo-1, 4-dihydroquinoline-3-carboxylic acid...
SourceID uspatents
SourceType Open Access Repository
Title Stable crystal of 4-oxoquinoline compound
URI https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7635704
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSQM2U00Sk4A9VVODJF2TZGPwQJOhLmgbZXJaimmKGfiwal8_M49QE68I0wgmBg_4XphcYDbSLQC6pVivtLigJB-8uBJYvEMiXhdy-DPojMA80OkD5Xk5-YkpASlp-uCD1UAHgzJbGICW9rm6eXAzcAKNADbZ8kqKkSoNN0EGtgCwqBADU2qeCIMmsF2XlJOqkFxUCWyR5SjkpymY6OZXAAvmzDzQzTlAGWDeBN1yJMqg4OYa4uyhCzc3Pr0ItF4l3gBqv7EYAwuw354qwaBgkZpqkZhsATpB3gjYLUhJAjb1zVJNEk2BmcjY3DRFkkESpzFSeOSkGbiMoJcYGBnJMLCUFJWmygJrxpIkObC3ASYHbXQ
link.rule.ids 230,309,783,805,888,64367
linkProvider USPTO
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSQM2U00Sk4A9VVODJF2TZGPwQJOhLmgbZXJaimmKGfiwal8_M49QE68I0wgmBg_4XphcYDbSLQC6pVivtLigJB-8uBJYvEMiXhdy-DPojMA80OkD5Xk5-YkpASlp-uCD1UAHg7IC61gzcJfMzYObgRNoCLDRlldSjFRtuAkysAWARYUYmFLzRBg0gS27pJxUheSiSmCbLEchP03BRDe_Alg0Z-aB7s4BygBzJ-ieI1EGBTfXEGcPXbi58elFoBUr8QZQFxiLMbAAe-6pEgwKFqmpFonJFqAz5I2AHYOUJGBj3yzVJNEUmI2MzU1TJBkkcRojhUdOnoEjwMUt3sfTz1uagcsIeqOBkZEMA0tJUWmqLLCaLEmSA4cAALRFcHE
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Stable+crystal+of+4-oxoquinoline+compound&rft.inventor=Satoh%2C+Motohide&rft.inventor=Motomura%2C+Takahisa&rft.inventor=Matsuda%2C+Takashi&rft.inventor=Kondo%2C+Kentaro&rft.inventor=Ando%2C+Koji&rft.inventor=Matsuda%2C+Koji&rft.inventor=Miyake%2C+Shuji&rft.inventor=Uehara%2C+Hideto&rft.number=7635704&rft.date=2009-12-22&rft.externalDBID=n%2Fa&rft.externalDocID=07635704